These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 31285290)

  • 1. The contribution of infection and the respiratory microbiome in acute exacerbations of idiopathic pulmonary fibrosis.
    Invernizzi R; Molyneaux PL
    Eur Respir Rev; 2019 Jun; 28(152):. PubMed ID: 31285290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis.
    Molyneaux PL; Cox MJ; Wells AU; Kim HC; Ji W; Cookson WO; Moffatt MF; Kim DS; Maher TM
    Respir Res; 2017 Feb; 18(1):29. PubMed ID: 28143484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of infection in the pathogenesis of idiopathic pulmonary fibrosis.
    Molyneaux PL; Maher TM
    Eur Respir Rev; 2013 Sep; 22(129):376-81. PubMed ID: 23997064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis.
    O'Dwyer DN; Ashley SL; Gurczynski SJ; Xia M; Wilke C; Falkowski NR; Norman KC; Arnold KB; Huffnagle GB; Salisbury ML; Han MK; Flaherty KR; White ES; Martinez FJ; Erb-Downward JR; Murray S; Moore BB; Dickson RP
    Am J Respir Crit Care Med; 2019 May; 199(9):1127-1138. PubMed ID: 30789747
    [No Abstract]   [Full Text] [Related]  

  • 5. The Lung Microbiome in Idiopathic Pulmonary Fibrosis: A Promising Approach for Targeted Therapies.
    Fastrès A; Felice F; Roels E; Moermans C; Corhay JL; Bureau F; Louis R; Clercx C; Guiot J
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29258183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topographic heterogeneity of lung microbiota in end-stage idiopathic pulmonary fibrosis: the Microbiome in Lung Explants-2 (MiLEs-2) study.
    Valenzi E; Yang H; Sembrat JC; Yang L; Winters S; Nettles R; Kass DJ; Qin S; Wang X; Myerburg MM; Methé B; Fitch A; Alder JK; Benos PV; McVerry BJ; Rojas M; Morris A; Kitsios GD
    Thorax; 2021 Mar; 76(3):239-247. PubMed ID: 33268457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis.
    Molyneaux PL; Cox MJ; Willis-Owen SA; Mallia P; Russell KE; Russell AM; Murphy E; Johnston SL; Schwartz DA; Wells AU; Cookson WO; Maher TM; Moffatt MF
    Am J Respir Crit Care Med; 2014 Oct; 190(8):906-13. PubMed ID: 25184687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The respiratory microbiome in idiopathic pulmonary fibrosis.
    Hewitt RJ; Molyneaux PL
    Ann Transl Med; 2017 Jun; 5(12):250. PubMed ID: 28706918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of the Lung's Microbiome in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis.
    Spagnolo P; Molyneaux PL; Bernardinello N; Cocconcelli E; Biondini D; Fracasso F; Tiné M; Saetta M; Maher TM; Balestro E
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiome in lung explants of idiopathic pulmonary fibrosis: a case-control study in patients with end-stage fibrosis.
    Kitsios GD; Rojas M; Kass DJ; Fitch A; Sembrat JC; Qin S; Veraldi KL; Gibson KF; Lindell K; Pilewski JM; Methe B; Li K; McDyer J; McVerry BJ; Morris A
    Thorax; 2018 May; 73(5):481-484. PubMed ID: 28802277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candidate Role for Toll-like Receptor 3 L412F Polymorphism and Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
    McElroy AN; Invernizzi R; Laskowska JW; O'Neill A; Doroudian M; Moghoofei M; Mostafaei S; Li F; Przybylski AA; O'Dwyer DN; Bowie AG; Fallon PG; Maher TM; Hogaboam CM; Molyneaux PL; Hirani N; Armstrong ME; Donnelly SC
    Am J Respir Crit Care Med; 2022 Mar; 205(5):550-562. PubMed ID: 34985402
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk factors for acute exacerbation of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
    Qiu M; Chen Y; Ye Q
    Clin Respir J; 2018 Mar; 12(3):1084-1092. PubMed ID: 28332341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host-Microbial Interactions in Idiopathic Pulmonary Fibrosis.
    Molyneaux PL; Willis-Owen SAG; Cox MJ; James P; Cowman S; Loebinger M; Blanchard A; Edwards LM; Stock C; Daccord C; Renzoni EA; Wells AU; Moffatt MF; Cookson WOC; Maher TM
    Am J Respir Crit Care Med; 2017 Jun; 195(12):1640-1650. PubMed ID: 28085486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectious respiratory pathogens among patients with acute exacerbation of idiopathic pulmonary fibrosis during the coronavirus disease 2019 pandemic in Japan.
    Akata K; Yamasaki K; Kawaguchi T; Chiba Y; Sennari K; Shigemi S; Nemoto K; Funada M; Suzuki K; Yatera K
    Heart Lung; 2024; 67():1-4. PubMed ID: 38569435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute exacerbation of idiopathic pulmonary fibrosis: a clinical review.
    Luppi F; Cerri S; Taddei S; Ferrara G; Cottin V
    Intern Emerg Med; 2015 Jun; 10(4):401-11. PubMed ID: 25672832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal models of acute exacerbation of pulmonary fibrosis.
    Ye X; Zhang M; Gu H; Liu M; Zhao Y; Shi Y; Wu S; Jiang C; Ye X; Zhu H; Li Q; Huang X; Cao M
    Respir Res; 2023 Nov; 24(1):296. PubMed ID: 38007420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the lung microbiome as a therapeutic target in the management of idiopathic pulmonary fibrosis: role of antioxidant/antibiotic combination therapy.
    Varone F; Gibiino G; Gasbarrini A; Richeldi L
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6379-6386. PubMed ID: 31364146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired diversity of the lung microbiome predicts progression of idiopathic pulmonary fibrosis.
    Takahashi Y; Saito A; Chiba H; Kuronuma K; Ikeda K; Kobayashi T; Ariki S; Takahashi M; Sasaki Y; Takahashi H
    Respir Res; 2018 Feb; 19(1):34. PubMed ID: 29486761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis.
    Invernizzi R; Wu BG; Barnett J; Ghai P; Kingston S; Hewitt RJ; Feary J; Li Y; Chua F; Wu Z; Wells AU; George PM; Renzoni EA; Nicholson AG; Rice A; Devaraj A; Segal LN; Byrne AJ; Maher TM; Lloyd CM; Molyneaux PL
    Am J Respir Crit Care Med; 2021 Feb; 203(3):339-347. PubMed ID: 32692582
    [No Abstract]   [Full Text] [Related]  

  • 20. Danger-associated molecular patterns and danger signals in idiopathic pulmonary fibrosis.
    Ellson CD; Dunmore R; Hogaboam CM; Sleeman MA; Murray LA
    Am J Respir Cell Mol Biol; 2014 Aug; 51(2):163-8. PubMed ID: 24749648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.